The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

The Globe and Mail has
updated our Stock Quote Pages
You are about to experience the newly designed Stock Quote Pages format. With the new layout, you'll enjoy a more in-depth look at the companies you're following and pages that are easier to navigate. This Editors' blog post explains why we've made these changes.

 

CVS Health Corp

NYSE: CVS
Last

(U.S.) $97.89

Today's change+0.02 +0.02%
Updated December 24 1:01 PM EST. Delayed by at least 15 minutes.
 

CVS Health Corp

NYSE: CVS
Last

(U.S.) $97.89

Today's change+0.02 +0.02%
Updated December 24 1:01 PM EST. Delayed by at least 15 minutes.

CVS Health Corp up slightly

CVS Health Corp closed up just (U.S.)$0.02 Wednesday to (U.S.)$97.89. Over the last five days, shares have gained 3.95% and 36.78% year to date. Shares have outperformed the S&P 500 by 24.35% during the last year.

Key company metrics

  • Open(U.S.) $97.90
  • Previous close(U.S.) $97.87
  • High(U.S.) $98.48
  • Low(U.S.) $97.73
  • Bid / Ask-- / --
  • YTD % change+36.78%
  • Volume2,590,411
  • Average volume (10-day)5,878,285
  • Average volume (1-month)4,580,852
  • Average volume (3-month)4,728,386
  • 52-week range(U.S.) $64.95 to (U.S.) $98.48
  • Beta1.07
  • Trailing P/E25.27×
  • P/E 1 year forward21.78×
  • Forward PEG1.46×
  • Indicated annual dividend(U.S.) $1.40
  • Dividend yield1.43%
  • Trailing EPS(U.S.) $3.87
Updated December 24 1:01 PM EST. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
+3.39%

Based on its net profit margin of 3.39%, CVS Health Corp is less effective than other companies in its industry at turning revenues into bottom line profit.
Company Books

S&P TSX0.10%Sector:Non-Cyclical Consumer Goods & ServicesIndustry:Retail - Drugs
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q3/2014Q2/2014Q1/2014Q4/2013
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedSep 30, 201409/30/2014Jun 30, 201406/30/2014Mar 31, 201403/31/2014Dec 31, 201312/31/2013
Revenue35,02134,60232,68932,782
Total other revenue--------
Total revenue35,02134,60232,68932,782
Gross profit6,4686,3245,9426,331
Total cost of revenue28,55328,27826,74726,451
Total operating expense33,29632,39430,66530,573
Selling / general / administrative4,2224,1163,9184,122
Research & development--------
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)521----0
Other operating expenses, total--------
Operating income1,7252,2082,0242,209
Interest income (expense), net non-operating-158-161-161-138
Gain (loss) on sale of assets--------
Other--------
Income before tax1,5722,0501,8662,074
Income after tax9481,2461,1291,262
Income tax, total624804737812
Net income9481,2461,1291,261
Total adjustments to net income--------
Net income before extra. items9481,2461,1291,262
Minority interest------0
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items9481,2461,1291,262
Inc. avail. to common incl. extra. items9481,2461,1291,261
Diluted net income9481,2461,1291,261
Dilution adjustment--------
Diluted weighted average shares1,1641,1741,1901,202
Diluted EPS excluding extraordinary itemsvalue per share0.811.060.951.05
Dividends per sharevalue per share0.280.280.280.23
Diluted normalized EPSvalue per share1.081.060.951.05